| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(72)90502-8 |
| P698 | PubMed publication ID | 4125201 |
| P2093 | author name string | D N Kerr | |
| P R Uldall | |||
| D Tacchi | |||
| P433 | issue | 7752 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 693-694 | |
| P577 | publication date | 1972-03-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Sterility and cyclophosphamide | |
| P478 | volume | 1 |
| Q42234441 | A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood |
| Q40502354 | Antineoplastic agents and their oral manifestations |
| Q88230199 | Childhood Urologic Cancer Therapy Related Sequelae and Their Impact on Management |
| Q54495737 | Chlorambucil in the treatment of systemic lupus erythematosus |
| Q40154586 | Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases |
| Q53771727 | Controlled trial of cyclophosphamide in idiopathic membranous nephropathy |
| Q53774849 | Cyclophosphamide and reproductive function. |
| Q93730340 | Cyclophosphamide and the prepubertal testis |
| Q93730388 | Cyclophosphamide therapy and sterility |
| Q93723730 | Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome |
| Q69612087 | Cyclophosphamide-Induced Ovarian Failure |
| Q73347992 | Cytotoxic endocrinopathy: a legacy of insults |
| Q38888865 | Disorders of endocrine function following cancer therapies. |
| Q40162851 | Disorders of the endocrine system due to radiation and cytotoxic chemotherapy |
| Q39780277 | Drug Treatment of Breast Cancer |
| Q34247887 | Drug-Induced Infertility |
| Q48387081 | Effects of Childhood Leukemia and Chemotherapy on Puberty and Reproductive Function in Girls |
| Q40296453 | Effects of cancer chemotherapy on gonadal function of patients |
| Q39521325 | Effects of cancer treatment on the reproductive system |
| Q93730336 | Familial Hodgkin's disease |
| Q38246219 | Fertility preservation in patients receiving cyclophosphamide therapy for renal disease |
| Q40147163 | Gonadal Injury Resulting From Chemotherapy |
| Q33332510 | Immunosuppressives in uveitis. A preliminary report of experience with chlorambucil |
| Q33578853 | Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide |
| Q39821025 | Late effects of treatment of cancer in children |
| Q39343445 | Letter: Drug levels in epilepsy |
| Q39343457 | Letter: Successful pregnancy in acute leukaemia |
| Q70024382 | Long-term assessment of cyclophosphamide therapy for nephrosis in children |
| Q54637158 | Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome. |
| Q48514939 | Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide |
| Q40426169 | Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy |
| Q50948321 | Occupational Exposure to Antineoplastic Agents and Self-Reported Infertility Among Nurses and Pharmacists |
| Q46925234 | Ovarian failure in SLE patients using pulse cyclophosphamide: comparison of different regimes |
| Q35776251 | Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients |
| Q41933644 | Pituitary-gonadal function in women following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study |
| Q67244623 | Plasma gonadotropins and gonadal steroids in children treated with cyclophosphamide |
| Q66960674 | Pregnancy following chemotherapy for an ovarian immature embryonal teratoma |
| Q34302895 | Problems with immunosuppressive agents in renal disease |
| Q70280499 | Prospects for fertility after chemotherapy or radiation for neoplastic disease |
| Q73345148 | Realizing the promise of apoptosis-based therapies: separating the living from the clinically undead |
| Q50802578 | The effect of cyclophosphamide on mouse oocyte in vitro fertilization and cleavage: Recovery |
| Q40252848 | The effects of antineoplastic therapy on growth and development in children. |
| Q69503848 | Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome |
| Q37118482 | Therapy Insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease |
| Q28363829 | Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil |
| Q39922166 | “Immunosuppressive” treatment of “chronic glomerulonephritis” |
Search more.